Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8486937
APP PUB NO 20110319407A1
SERIAL NO

13165370

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nACh receptors), activation of nACh receptors, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds (e.g., indazoles and benzothiazoles), which act as ligands for the α7 nACh receptor subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEMORY PHARMACEUTICALS CORPORATIONMONTVALE NJ 07645

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gauss, Carla Maria New York, US 15 369
Herbert, Brian Stockholm, US 30 507
Ma, Jianguo Montvale, US 63 707
Nguyen, Truc Minh New York, US 23 424
Schumacher, Richard A Monroe, US 58 834
Tehim, Ashok Ridgewood, US 111 824
Xie, Wenge Mahwah, US 38 556

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 16, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00